• China
  • English


Location:Home > About us > Introduce

Changshan ConjuChem biological pharmaceutical R & D (Hebei) Co., Ltd. established on March 22,2013. is a Sino-foreign joint venture established by Hebei Changshanjiukang Biological Technology Co., Ltd. which was a wholly owned subsidiary of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(Stock Code: 300255) and the ConjuChem LLC(USA).  The registered capital of JV is 20 million yuan, and a total investment of 40million yuan .The company mainly engaged in biotechnology products in the areas of technology development, technical advice, technical cooperation, technology transfer and technical services. As a powerful combination established biological medical high-tech enterprise, we not only have advanced medical equipment but also have a high specialization degree and management  standardization  research group. The group has a good record of drug research and development which successfully developed and commercialized a new Anticancer chemotherapy drugs: Type of paclitaxel combined with albumin nanoparticles (ABRAXANE ®). Since 2005, the drug has come into more than 30 countries which include The United States, China, Europe and other countries. It was widely used in breast cancer, lung cancer, and achieved good economic benefit. The company has clinical laboratories in USA, Canada and China and the currently tasks is to research and development the diabetes drugs. The company build a  international level quality control system which can enable a reliable and stable quality product.
  Changshan ConjuChem biological pharmaceutical R & D (Hebei) Co., Ltd. strictly adheres it’s mission, “love life, quality first”, continue to deepen reform and innovation, we strive to become a well-known high-tech biological pharmaceutical research and development enterprise.


@ COPYRIGHT 2013. Changshan ConjuChem biological pharmaceutical R&D Co.,Ltd .